Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Highly sensitive cell-based assay to detect the presence of active botulinum neurotoxin serotype-A

Highly sensitive cell-based assay to detect the presence of active botulinum neurotoxin serotype-A

US Patent 10451621 · Granted Oct 22, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Imidazopyrimidines as EED inhibitors and the use thereof2024
Anti-CD39 antibodies and use thereof2024
Fused 1,4-oxazepines as BET protein degraders2022
Immuno-based botulinum toxin serotype A activity assays2022
Immuno-based botulinum toxin serotype A activity assays2022
BET bromodomain protein degraders with cleavable linkers2022
Immuno-based botulinum toxin serotype A activity assays2022
Immuno-based botulinum toxin serotype A activity assays2022
Treatment of psychological trauma2021
Botulinum neurotoxin for treatment of disorders associated with melanocyte hyper2021
Immuno-based retargeted endopeptidase activity assays2021
Immuno-based retargeted endopeptidase activity assays2021